A transcriptional switch governs fibroblast activation in heart disease

Michael Alexanian(Gladstone Institutes), Pawel F. Przytycki(Gladstone Institutes), Rudi Micheletti(Howard Hughes Medical Institute), Arun Padmanabhan(Gladstone Institutes), Lin Ye(Gladstone Institutes), Joshua G. Travers(University of Colorado Anschutz Medical Campus), Bárbara González‐Terán(Gladstone Institutes), Ana Catarina Silva(Gladstone Institutes), Qiming Duan(Gladstone Institutes), Sanjeev S. Ranade(Gladstone Institutes), Franco Felix(Gladstone Institutes), Ricardo Linares-Saldana(Cardiovascular Institute of the South), Li Li(Gladstone Institutes), Clara Youngna Lee(Gladstone Institutes), Nandhini Sadagopan(Gladstone Institutes), Angelo Pelonero(Gladstone Institutes), Yu Huang(Gladstone Institutes), Gaia Andreoletti(University of California, San Francisco), Rajan Jain(Cardiovascular Institute of the South), Timothy A. McKinsey(University of Colorado Anschutz Medical Campus), Michael G. Rosenfeld(Howard Hughes Medical Institute), Casey A. Gifford(Gladstone Institutes), Katherine S. Pollard(Gladstone Institutes), Saptarsi M. Haldar(Gladstone Institutes), Deepak Srivastava(Gladstone Institutes)
Nature
June 23, 2021
Cited by 225Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis